Interventional Care
Our CATALYST Program supports our customers in improving clinical metrics, with a focus on reducing CLABSIs. Through this collaborative framework, we emphasize real world process improvements and outcomes in healthcare facilities employing best practices.
To demonstrate our confidence in Prevantics® Device Swab, we offer a money-back guarantee to program customers. Together, we can drive positive change in healthcare.
Our CATALYST Program supports our customers in improving clinical metrics, with a focus on reducing CLABSIs. Through this collaborative framework, we emphasize real world process improvements and outcomes in healthcare facilities employing best practices.
To demonstrate our confidence in Prevantics® Device Swab, we offer a money-back guarantee to program customers. Together, we can drive positive change in healthcare.
Roadmap
Follow the steps to learn how PDI’s CATALYST Program works.
Step 1
- Meet with leaders to discuss and analyze real-time CLABSI data
- Review current CLABSI policy and practice
- Determine trial unit locations
For eligibility requirements, email Holly Montejano, PDI Director of Clinical Education and Program Development
Resources
Step 2
- Conduct facility assessment for policy and protocol compliance (required)
- Summarize findings and outline recommendations
- Provide implementation strategies, including education and support
Step 3
- Track and monitor progress toward CLABSI reduction goals
- Ongoing product education and utilization review
- Ongoing clinical education and consultation
Resources
- Prevantics® Device Swab and Strip Instructions for Use
- Industry Guidelines
Step 4
- Share product success
- Assist facility with standardized product utilization
Helpful Resources
Education
The Use of Chlorhexidine Gluconate Alcohol Hub Disinfection to Prevent CLABSIs
The Use of 3.15% Chlorhexidine Gluconate/70% Alcohol Hub Disinfection to Prevent Central Line-Associated Blood Stream Infections in Dialysis Patients …
Prevantics® Device Swab Clinical Compendium
The Prevantics Device Swab Clinical Compendium provides a complete guide to efficacy data, clinical studies and safety information for the product.
Device Disinfection: Dare to Compare
This video provides an overview of the benefits of Prevantics® Device Swab and how it compares to alternative options for…
Spotlight on Chlorhexidine Gluconate (CHG) and Its Sidekick Alcohol
This course qualifies for 1 CE / 1 IPU and corresponds to the following Infection Prevention Unit (IPU) domain(s): Identification…
Blogs
The Other Ones: BSIs Without the CVC
Prior to 2020, there had been a significant ongoing and sustained reduction in the rate of central line-associated...
A Unique Perspective on National Compliance Rates to the Central-Line Bundle
Every Infection Preventionist should know what The Center for Disease Control and Prevention’s (CDC) bundle checklist is to...
Prevention of Intraluminal Contamination of Intravascular Catheters
Despite a 46% reduction in central line-associated bloodstream infections (CLABSIs) in US healthcare facilities from 2008-2013, an estimated...
Request More Information
Complete the form to connect with our Director of Clinical Education and Program Development
to learn more about how to enroll in the Catalyst Program.
1https://arpsp.cdc.gov/profile/nhsn/clabsi
2https://www.ahrq.gov/hai/pfp/haccost2017-results.html#:~:text=Central%20Line%2DAssociated%20Bloodstream%20Infections,-Based%20on%20seven&text=Individual%20studies%20produced%20a%20broad,%2418%2C000%20to%20more%20than%20%2490%2C000 (23,389 x $48,108 (AHRQ cost avg CLABSI) = $1.13B)